Provided by Tiger Trade Technology Pte. Ltd.

Scholar Rock Holding Corp

46.81
+0.65001.41%
Post-market: 46.55-0.2600-0.56%19:30 EDT
Volume:1.24M
Turnover:58.20M
Market Cap:5.70B
PE:-13.93
High:47.80
Open:46.74
Low:46.08
Close:46.16
52wk High:61.76
52wk Low:27.07
Shares:121.79M
Float Shares:107.73M
Volume Ratio:0.90
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3601
EPS(LYR):-3.4845
ROE:-167.77%
ROA:-58.82%
PB:22.46
PE(LYR):-13.43

Loading ...

Scholar Rock Poised for De-risked Commercial Ramp in Neuromuscular Space, Wedbush Says

MT Newswires Live
·
Sep 26

Scholar Rock added to Best Ideas List at Wedbush

TIPRANKS
·
Sep 25

Scholar Rock Holding is Maintained at Buy by Truist Securities

Dow Jones
·
Sep 25

Truist Lifts Price Target on Scholar Rock Holding to $77 From $76, Keeps Buy Rating

MT Newswires Live
·
Sep 24

Movement Alert|Scholar Rock Holding Corp Rises 5.09% in Regular Trading, Stock Remains Active Post-Isembyld FDA Approval and Commercial Launch

Market Focus
·
Sep 23

Scholar Rock Grants Inducement Equity Awards Covering 83,102 Shares to New Hires

Reuters
·
Sep 22

Scholar Rock Reports New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 22

US Research Roundup-eBay, Sunbelt Rentals, T-Mobile

Reuters
·
Sep 21

Scholar Rock Holding Corporation : JP Morgan Raises Target Price to $70 from $63

THOMSON REUTERS
·
Sep 21

Analysts’ Top Healthcare Picks: Alnylam Pharma (ALNY), Scholar Rock Holding (SRRK)

TIPRANKS
·
Sep 16

Scholar Rock says FDA requested pregnancy safety study for Isembyld

TIPRANKS
·
Sep 16

Scholar Rock Shares Fall After Barclays Downgrade

MT Newswires Live
·
Sep 16

Scholar Rock Faces Early Isembyld Launch Friction From FDA Safety Requirements, Truist Says

MT Newswires Live
·
Sep 16

Scholar Rock Holding Price Target Raised to $70.00/Share from $64.00 by Wedbush

Dow Jones
·
Sep 15

Scholar Rock Holding Corporation : H.c. Wainwright Raises Target Price to $70 from $65

THOMSON REUTERS
·
Sep 15

U.S. Research Roundup-Eli Lilly, McDonald's, Welltower

Reuters
·
Sep 15

Scholar Rock downgraded to Equal Weight from Overweight at Barclays

TIPRANKS
·
Sep 15

Kestra Medical Technologies Q1 Revenue Beats Estimates, Raises FY Revenue Outlook

Reuters
·
Sep 15

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Amid AI Pullback

MT Newswires Live
·
Sep 14

Scholar Rock Says Its First Muscle-Targeted SMA Therapy Will Cost About $310,000 Annually

Reuters
·
Sep 14